Sichuan Huiyu Pharmaceutical Co Ltd (688553) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.016x

Based on the latest financial reports, Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥58.54 Million ≈ $8.57 Million USD) by net assets (CN¥3.72 Billion ≈ $544.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 688553 equity financing ratio to measure how much of total assets are equity-financed.

Sichuan Huiyu Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Sichuan Huiyu Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Sichuan Huiyu Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Sichuan Huiyu Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sichuan Huiyu Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Pet Acquisition LLC NASDAQ:WOOF	-0.051x
Yext Inc NYSE:YEXT	0.055x
Ironwood Pharmaceuticals Inc NASDAQ:IRWD	-0.024x
Oneness Biotech Co Ltd TWO:4743	0.001x
China Television Media Ltd SHG:600088	-0.005x
Basilea Pharmaceutica AG SW:BSLN	0.305x
Mengtian Home Group Inc. SHG:603216	N/A
Mobilicom Limited Warrants NASDAQ:MOBBW	-0.038x

Annual Cash Flow Conversion Efficiency for Sichuan Huiyu Pharmaceutical Co Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Sichuan Huiyu Pharmaceutical Co Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Sichuan Huiyu Pharmaceutical Co Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.97 Billion ≈ $581.43 Million	CN¥242.96 Million ≈ $35.55 Million	0.061x	+244.81%
2023-12-31	CN¥3.77 Billion ≈ $552.32 Million	CN¥66.93 Million ≈ $9.79 Million	0.018x	-66.02%
2022-12-31	CN¥3.72 Billion ≈ $544.07 Million	CN¥194.06 Million ≈ $28.40 Million	0.052x	-58.39%
2021-12-31	CN¥3.56 Billion ≈ $520.72 Million	CN¥446.36 Million ≈ $65.32 Million	0.125x	-75.70%
2020-12-31	CN¥751.48 Million ≈ $109.97 Million	CN¥387.95 Million ≈ $56.77 Million	0.516x	-35.33%
2019-12-31	CN¥408.65 Million ≈ $59.80 Million	CN¥326.22 Million ≈ $47.74 Million	0.798x	+193.22%
2018-12-31	CN¥-150.70 Million ≈ $-22.05 Million	CN¥129.06 Million ≈ $18.89 Million	-0.856x	-1305.63%
2017-12-31	CN¥-185.32 Million ≈ $-27.12 Million	CN¥-13.16 Million ≈ $-1.93 Million	0.071x	--

About Sichuan Huiyu Pharmaceutical Co Ltd

SHG:688553 China Drug Manufacturers - Specialty & Generic

Market Cap

$686.19 Million

CN¥4.69 Billion CNY

Market Cap Rank

#10647 Global

#2876 in China

Share Price

CN¥11.07

Change (1 day)

+0.36%

52-Week Range

CN¥9.86 - CN¥27.61

All Time High

CN¥38.07